The PI3K/AKT/mTOR pathway is instrumental in EMT in malignant tumours, aiding in the transition to a more aggressive phenotype [8], which is essential in aspects such as cell survival, growth, proliferation, angiogenesis, transcription, translation and metabolism [9]. The gene discussed is AKT1; the disease is neoplasm.